Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Tocolytic drugs for use in veterinary obstetrics.

The Canadian veterinary journal = La revue veterinaire canadienne

Ménard L.
PMID: 17422462
Can Vet J. 1984 Oct;25(10):389-93.

THE AUTHOR PRESENTS A LITERATURE REVIEW OF TWO TOCOLYTIC AGENTS USED IN VETERINARY OBSTETRICS: isoxsuprine and clenbuterol. The medical background from which these drugs emerged for human use and to which is linked their application in animal medicine is...

Cite
Ménard L. Tocolytic drugs for use in veterinary obstetrics. Can Vet J. 1984;25(10):389-93
Ménard, L. (1984). Tocolytic drugs for use in veterinary obstetrics. The Canadian veterinary journal = La revue veterinaire canadienne, 25(10), 389-93.
Ménard, L. "Tocolytic drugs for use in veterinary obstetrics." The Canadian veterinary journal = La revue veterinaire canadienne vol. 25,10 (1984): 389-93.
Ménard L. Tocolytic drugs for use in veterinary obstetrics. Can Vet J. 1984 Oct;25(10):389-93. PMID: 17422462; PMCID: PMC1790663.
Copy Download .nbib Format: NLM
Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Hejazi RA, Mandourah NA, Alsulami AS, Bakhsh HT, Diri RM, Noor AO.
PMID: 34194255
Saudi Pharm J. 2021 Jun;29(6):487-496. doi: 10.1016/j.jsps.2021.02.001. Epub 2021 Feb 16.

INTRODUCTION: Sickle-cell disease (SCD) is one of the most common hematologic inherited disorders in Saudi Arabia. Vaso-occlusive pain crisis in SCD is a major cause for emergency visits and patients' pain may be undertreated. This study presents a narrative...

Cite
Hejazi RA, Mandourah NA, Alsulami AS, et al. Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review. Saudi Pharm J. 2021;29(6):487-496doi: 10.1016/j.jsps.2021.02.001.
Hejazi, R. A., Mandourah, N. A., Alsulami, A. S., Bakhsh, H. T., Diri, R. M., & Noor, A. O. (2021). Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 29(6), 487-496. https://doi.org/10.1016/j.jsps.2021.02.001
Hejazi, Reem A, et al. "Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 29,6 (2021): 487-496. doi: https://doi.org/10.1016/j.jsps.2021.02.001
Hejazi RA, Mandourah NA, Alsulami AS, Bakhsh HT, Diri RM, Noor AO. Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review. Saudi Pharm J. 2021 Jun;29(6):487-496. doi: 10.1016/j.jsps.2021.02.001. Epub 2021 Feb 16. PMID: 34194255; PMCID: PMC8233527.
Copy Download .nbib Format: NLM
Interventions for treating leg ulcers in people with sickle cell disease.

The Cochrane database of systematic reviews

Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ.
PMID: 34559425
Cochrane Database Syst Rev. 2021 Jan 09;1:CD008394. doi: 10.1002/14651858.CD008394.pub4.

BACKGROUND: The frequency of skin ulceration makes an important contributor to the morbidity burden in people with sickle cell disease. Many treatment options are available to the healthcare professional, although it is uncertain which treatments have been assessed for...

Cite
Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev. 2021;1:CD008394doi: 10.1002/14651858.CD008394.pub4.
Martí-Carvajal, A. J., Knight-Madden, J. M., & Martinez-Zapata, M. J. (2021). Interventions for treating leg ulcers in people with sickle cell disease. The Cochrane database of systematic reviews, 1CD008394. https://doi.org/10.1002/14651858.CD008394.pub4
Martí-Carvajal, Arturo J, et al. "Interventions for treating leg ulcers in people with sickle cell disease." The Cochrane database of systematic reviews vol. 1 (2021): CD008394. doi: https://doi.org/10.1002/14651858.CD008394.pub4
Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev. 2021 Jan 09;1:CD008394. doi: 10.1002/14651858.CD008394.pub4. PMID: 34559425; PMCID: PMC8407242.
Copy Download .nbib Format: NLM
A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations.

Talanta

Sane RT, Nayak VG, Malkar VB.
PMID: 18963780
Talanta. 1985 Jan;32(1):31-3. doi: 10.1016/0039-9140(85)80010-2.

A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate is described, based on measurement of the orangeyellow species produced when the drugs are coupled with diazotized benzocaine (p-aminoethyl benzoate) in trimethylamine medium. The...

Cite
Sane RT, Nayak VG, Malkar VB. A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations. Talanta. 1985;32(1):31-3doi: 10.1016/0039-9140(85)80010-2.
Sane, R. T., Nayak, V. G., & Malkar, V. B. (1985). A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations. Talanta, 32(1), 31-3. https://doi.org/10.1016/0039-9140(85)80010-2
Sane, R T, et al. "A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations." Talanta vol. 32,1 (1985): 31-3. doi: https://doi.org/10.1016/0039-9140(85)80010-2
Sane RT, Nayak VG, Malkar VB. A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations. Talanta. 1985 Jan;32(1):31-3. doi: 10.1016/0039-9140(85)80010-2. PMID: 18963780.
Copy Download .nbib Format: NLM
A simple spectrophotometric method for determination of isoxsuprine hydrochloride in pharmaceuticals.

Talanta

Rajeswari CV, Naidu DV, Naidu NV, Naidu PR.
PMID: 18964503
Talanta. 1988 Mar;35(3):237-8. doi: 10.1016/0039-9140(88)80073-0.

A spectrophotometric method has been developed for the determination of isoxsuprine hydrochloride and its dosage forms, based on its coupling reaction with diazotized sulphanilic acid. The yellow chromophore has an absorption maximum at 440 nm. Beer's law holds over...

Cite
Rajeswari CV, Naidu DV, Naidu NV, et al. A simple spectrophotometric method for determination of isoxsuprine hydrochloride in pharmaceuticals. Talanta. 1988;35(3):237-8doi: 10.1016/0039-9140(88)80073-0.
Rajeswari, C. V., Naidu, D. V., Naidu, N. V., & Naidu, P. R. (1988). A simple spectrophotometric method for determination of isoxsuprine hydrochloride in pharmaceuticals. Talanta, 35(3), 237-8. https://doi.org/10.1016/0039-9140(88)80073-0
Rajeswari, C V, et al. "A simple spectrophotometric method for determination of isoxsuprine hydrochloride in pharmaceuticals." Talanta vol. 35,3 (1988): 237-8. doi: https://doi.org/10.1016/0039-9140(88)80073-0
Rajeswari CV, Naidu DV, Naidu NV, Naidu PR. A simple spectrophotometric method for determination of isoxsuprine hydrochloride in pharmaceuticals. Talanta. 1988 Mar;35(3):237-8. doi: 10.1016/0039-9140(88)80073-0. PMID: 18964503.
Copy Download .nbib Format: NLM
[Not Available].

Canadian family physician Medecin de famille canadien

Latulippe L.
PMID: 21283321
Can Fam Physician. 1983 Feb;29:296-9.

Raynaud's phenomenon can be idiopathic (Raynaud's disease) and is found in healthy individuals or secondary to various conditions. Our perception of Raynaud's phenomenon has made a clear progression, partly due to a more useful set of diagnostic criteria for...

Cite
Latulippe L. Le Phénomène de Raynaud. [Not Available]. Can Fam Physician. 1983;29:296-9
Latulippe, L. (1983). Le Phénomène de Raynaud. [Not Available]. Canadian family physician Medecin de famille canadien, 29296-9.
Latulippe, L. "Le Phénomène de Raynaud." [Not Available]. Canadian family physician Medecin de famille canadien vol. 29 (1983): 296-9.
Latulippe L. Le Phénomène de Raynaud. [Not Available]. Can Fam Physician. 1983 Feb;29:296-9. French. PMID: 21283321; PMCID: PMC2153761.
Copy Download .nbib Format: NLM
Interventions for treating leg ulcers in people with sickle cell disease.

The Cochrane database of systematic reviews

Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ.
PMID: 34559425
Cochrane Database Syst Rev. 2021 Jan 09;1:CD008394. doi: 10.1002/14651858.CD008394.pub4.

BACKGROUND: The frequency of skin ulceration makes an important contributor to the morbidity burden in people with sickle cell disease. Many treatment options are available to the healthcare professional, although it is uncertain which treatments have been assessed for...

Cite
Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev. 2021;1:CD008394doi: 10.1002/14651858.CD008394.pub4.
Martí-Carvajal, A. J., Knight-Madden, J. M., & Martinez-Zapata, M. J. (2021). Interventions for treating leg ulcers in people with sickle cell disease. The Cochrane database of systematic reviews, 1CD008394. https://doi.org/10.1002/14651858.CD008394.pub4
Martí-Carvajal, Arturo J, et al. "Interventions for treating leg ulcers in people with sickle cell disease." The Cochrane database of systematic reviews vol. 1 (2021): CD008394. doi: https://doi.org/10.1002/14651858.CD008394.pub4
Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev. 2021 Jan 09;1:CD008394. doi: 10.1002/14651858.CD008394.pub4. PMID: 34559425; PMCID: PMC8407242.
Copy Download .nbib Format: NLM
Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial.

Electronic physician

Alavi A, Rajaee M, Amirian M, Mahboobi H, Jahanshahi KA, Faghihi A.
PMID: 26396726
Electron Physician. 2015 Aug 10;7(4):1144-9. doi: 10.14661/2015.1144-1149. eCollection 2015 Aug.

BACKGROUND: Isoxsuprine (Vasodilan) is a beta-adrenergic that directly affects the vascular smooth muscle and results in peripheral vascular dilation. Isoxsuprine relaxes the uterine smooth muscles and is used for treatment of pre-term labor and dysmenorrhea. Isoxsuprine is used extensively...

Cite
Alavi A, Rajaee M, Amirian M, et al. Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial. Electron Physician. 2015;7(4):1144-9doi: 10.14661/2015.1144-1149.
Alavi, A., Rajaee, M., Amirian, M., Mahboobi, H., Jahanshahi, K. A., & Faghihi, A. (2015). Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial. Electronic physician, 7(4), 1144-9. https://doi.org/10.14661/2015.1144-1149
Alavi, Azin, et al. "Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial." Electronic physician vol. 7,4 (2015): 1144-9. doi: https://doi.org/10.14661/2015.1144-1149
Alavi A, Rajaee M, Amirian M, Mahboobi H, Jahanshahi KA, Faghihi A. Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial. Electron Physician. 2015 Aug 10;7(4):1144-9. doi: 10.14661/2015.1144-1149. eCollection 2015 Aug. PMID: 26396726; PMCID: PMC4578532.
Copy Download .nbib Format: NLM
Surgical treatment of navicular syndrome in the horse using navicular suspensory desmotomy.

New Zealand veterinary journal

Bell BT, Bridge IS, Sullivan ST.
PMID: 16031887
N Z Vet J. 1996 Feb;44(1):26-30. doi: 10.1080/00480169.1996.35927.

Seventeen horses diagnosed as having navicular syndrome on the basis of history, clinical findings, regional local anaesthesia and radiography were subjected to bilateral navicular suspensory desmotomy. Before surgery, the duration of navicular lameness ranged from 6 weeks to 4...

Cite
Bell BT, Bridge IS, Sullivan ST. Surgical treatment of navicular syndrome in the horse using navicular suspensory desmotomy. N Z Vet J. 1996;44(1):26-30doi: 10.1080/00480169.1996.35927.
Bell, B. T., Bridge, I. S., & Sullivan, S. T. (1996). Surgical treatment of navicular syndrome in the horse using navicular suspensory desmotomy. New Zealand veterinary journal, 44(1), 26-30. https://doi.org/10.1080/00480169.1996.35927
Bell, B T, et al. "Surgical treatment of navicular syndrome in the horse using navicular suspensory desmotomy." New Zealand veterinary journal vol. 44,1 (1996): 26-30. doi: https://doi.org/10.1080/00480169.1996.35927
Bell BT, Bridge IS, Sullivan ST. Surgical treatment of navicular syndrome in the horse using navicular suspensory desmotomy. N Z Vet J. 1996 Feb;44(1):26-30. doi: 10.1080/00480169.1996.35927. PMID: 16031887.
Copy Download .nbib Format: NLM
Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic.

Annals of Saudi medicine

Al-Jam'a AH, Al-Dabbous IA, Rafiq MS, Al-Khatti A, Al-Salem AH, Al-Baharna A, Boholaiga M.
PMID: 17337943
Ann Saudi Med. 1999 Mar-Apr;19(2):97-100. doi: 10.5144/0256-4947.1999.97.

BACKGROUND: Isoxsuprine is a tocolytic agent which improves erythrocyte deformability. It was accidentally found to be effective in the management of sickle cell disease (SCD) painful crises. The experience with the drug in the treatment of sickle cell disease...

Cite
Al-Jam'a AH, Al-Dabbous IA, Rafiq MS, et al. Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic. Ann Saudi Med. 1999;19(2):97-100doi: 10.5144/0256-4947.1999.97.
Al-Jam'a, A. H., Al-Dabbous, I. A., Rafiq, M. S., Al-Khatti, A., Al-Salem, A. H., Al-Baharna, A., & Boholaiga, M. (1999). Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic. Annals of Saudi medicine, 19(2), 97-100. https://doi.org/10.5144/0256-4947.1999.97
Al-Jam'a, A H, et al. "Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic." Annals of Saudi medicine vol. 19,2 (1999): 97-100. doi: https://doi.org/10.5144/0256-4947.1999.97
Al-Jam'a AH, Al-Dabbous IA, Rafiq MS, Al-Khatti A, Al-Salem AH, Al-Baharna A, Boholaiga M. Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic. Ann Saudi Med. 1999 Mar-Apr;19(2):97-100. doi: 10.5144/0256-4947.1999.97. PMID: 17337943.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries